HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of novel human high-density lipoprotein receptor Up-regulators using a cell-based high-throughput screening assay.

Abstract
Scavenger receptor class B type I (SR-BI) is the high-affinity high-density lipoprotein (HDL) receptor, and CLA-1 is the human homologue of the murine SR-BI. CLA-1/SR-BI receptor has been suggested as a new preventative and/or therapeutic target for atherosclerosis due to its pivotal role in overall HDL cholesterol (HDL-C) metabolism and its antiatherogenic activity in vivo. To search for active compounds that can increase CLA-1 transcription, a novel cell-based assay was developed for application in high-throughput screening (HTS). Human hepatoma HepG2 cells were transfected with a CLA-1-promoter-luciferase reporter gene construct, and the stable transfected cell line was selected and named CLAp-LUC HepG2. With rosiglitazone as a positive control, this stable cell line was used to establish a specific CLA-1 gene expression assay in a 96-well microplate format. The evaluating parameter Z' value of 0.64 showed that this cell-based HTS assay was robust and reliable. Screening of 6000 microbial secondary metabolite crude extracts identified 8 positive strains. Between 2 identified CLA-1 up-regulators produced by actinomycete strain 04-4776, 4776B may stimulate not only the expression of CLA-1 on the transcriptional and translational levels but also the activity of CLA-1 to uptake the HDL-C in HepG2 cells. The active compounds originated from this HTS assay may be developed to drug candidates or lead compounds for new antiatherosclerosis agents.
AuthorsYuan Yang, Zhongbing Zhang, Wei Jiang, Lei Gao, Guiyu Zhao, Zhihui Zheng, Min Wang, Shuyi Si, Bin Hong
JournalJournal of biomolecular screening (J Biomol Screen) Vol. 12 Issue 2 Pg. 211-9 (Mar 2007) ISSN: 1087-0571 [Print] United States
PMID17259591 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbocyanines
  • Fluorescent Dyes
  • Isoflavones
  • Lipoproteins, HDL
  • PPAR gamma
  • Receptors, Lipoprotein
  • Recombinant Fusion Proteins
  • SCARB1 protein, human
  • Scavenger Receptors, Class B
  • Thiazolidinediones
  • high density lipoprotein receptors
  • Rosiglitazone
  • Hydroxyl Radical
  • 3,3'-dioctadecylindocarbocyanine
  • 4'-methoxy-3',5,7-trihydroxyisoflavone
  • Luciferases
Topics
  • Actinomycetaceae (metabolism)
  • Biological Assay (methods)
  • Carbocyanines
  • Carcinoma, Hepatocellular (pathology)
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical
  • Fermentation
  • Fluorescent Dyes
  • Gene Expression Regulation (drug effects)
  • Genes, Reporter
  • Humans
  • Hydroxyl Radical (chemistry)
  • Isoflavones (isolation & purification, pharmacology)
  • Lipoproteins, HDL (genetics, metabolism)
  • Liver Neoplasms (pathology)
  • Luciferases (metabolism)
  • PPAR gamma (agonists)
  • Receptors, Lipoprotein (genetics, metabolism)
  • Recombinant Fusion Proteins (metabolism)
  • Rosiglitazone
  • Scavenger Receptors, Class B (genetics, metabolism)
  • Thiazolidinediones (pharmacology)
  • Transcription, Genetic (drug effects)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: